1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with midaglizole in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (midaglizole) | Trials (midaglizole) | Recent Studies (post-2010) (midaglizole) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 65 | 5 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bewtra, AK; Hopp, RJ; Miyagawa, H; Okada, C; Sugiyama, H; Townley, RG | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and midaglizole
Article | Year |
---|---|
The effect of a selective alpha 2-adrenergic receptor antagonist (midaglizole) on the cyclic 3',5'-adenosine monophosphate production in human mononuclear cells.
Topics: Adrenergic alpha-Antagonists; Adult; Asthma; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Humans; Imidazoles; Isoproterenol; Leukocytes, Mononuclear; Male; Platelet Activating Factor | 1992 |